PSI - Issue 82

Krastena Nikolova et al. / Procedia Structural Integrity 82 (2026) 227–233 K. Nikolova et al./ Structural Integrity Procedia 00 (2026) 000–000

232

6

which can be difficult to clean. A critical step remains the transfer of knowledge from laboratory to clinical practice, accompanied by the optimization of protocols in order to minimize batch-to-batch variability. Acknowledgements This study was financed by the European Union – NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, project No. BG-RRP-2.004-0009-C02. References Alam, S., Akhtar, A., Ahsan, I., Shafiq-Un-Nabi, S., 2019. Pharmaceutical product development exploiting 3D printing technology: Conventional to novel drug delivery system. Curr. Pharm. Des. 24, pp. 5029–5038. Algahtani, M., Mohammed, A., Ahmad, J., Abdullah, M., Saleh, E., 2021. 3D Printing of Dapagliflozin Containing Self-Nanoemulsifying Tablets: Formulation Design and In Vitro Characterization. Pharmaceutics, 13, pp. 993. Al-Kinani, A.A., Zidan, G., Elsaid, N., Seyfoddin, A., Alani, A.W.G., Alany, R.G., 2018. Ophthalmic gels: Past, present and future, Adv. Drug Deliv. Rev., 126, pp. 113–126. https://doi.org/10.1016/j.addr.2017.12.017 Arafat, B., Wojsz, M., Isreb, A., Forbes, R.T., Isreb, M., Ahmed, W., Arafat, T., Alhnan, M.A., 2018. Tablet fragmentation without a disintegrant: a novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. Eur J Pharm Sci., 118, pp. 191-199. https://doi.org/10.1016/j.ejps.2018.03.019 Awad, A., Trenfield, S.J., Gaisford, S., Basit, A.W., 2018. 3D printed medicines: a new branch of digital healthcare, Int. J. Pharm., 548(1), pp. 586–596. https://doi.org/10.1016/j.ijpharm.2018.07.024 Azam, R.S.M., Zhang, M., Bhandari, B., Yang, C., 2018. Effect of Different Gums on Features of 3D Printed Object Based on Vitamin-D Enriched Orange Concentrate. Food Biophys., 13, pp. 250–262. Barber, B.W., Dumont, C., Caisse, P., Simon, G.P., Boyd, B.J., 2021. A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations. Pharmaceutics, 13, pp. 2107. Beer, N., Hegger, I., Kaae, S., De Bruin, M.L., Genina, N., Alves, T.L., Hoebert, J., Sporrong, S.K., 2021. Scenarios for 3D printing of personalized medicines—A case study. Explor. Res. Clin. Soc. Pharm., 4, 100073. Bloomquist, C.J., Mecham, M.B., Paradzinsky, M.D., Janusziewicz, R., Warner, S.B., Luft, J.C., Mecham, S.J., Wang, A.Z., DeSimone, J.M., 2018. Controlling release from 3D printed medical devices using CLIP and drug-loaded liquid resins, J. Controlled Release. 278, pp. 9–23, https://doi.org/10.1016/j.jconrel.2018.03.026. Du, J., Dai, H., Wang, H., Yu, Y., Zhu, H., Fu, Y., Ma, L., Peng, L., Li, L., Wang, Q., et al., 2021. Preparation of High Thermal Stability Gelatin Emulsion and Its Application in 3D Printing. Food Hydrocoll., 113, pp. 106536. Elahpour, N., Pahlevanzadeh, F., Kharaziha, M., Bakhsheshi-Rad, H.R., Ramakrishna, S., Berto, F., 2021. 3D printed microneedles for transdermal drug delivery: A brief review of two decades. Int. J. Pharm., 597, pp. 120301. Fina, F., Goyanes, A., Gaisford, S., Basit, A., 2017. Selective laser sintering (SLS) 3D printing of medicines, Int. J. Pharm., 529, pp. 285–293. Fisusi, F.A., Siew, A., Chooi, K.W., Okubanjo, O., Garrett, N., Lalatsa, K., Serrano, D., Summers, I., Moger, J., Stapleton, P., et al., 2016. Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels—A Strategy for Brain Cancer Treatments. Pharm. Res., 33, pp. 1289–1303. Fu, J., Yu, X., Jin, Y., 2018. 3D printing of vaginal rings with personalized shapes for controlled release of progesterone, Int. J. Pharm., 539(1–2), pp. 75–82. https://doi.org/10.1016/j.ijpharm.2018.01.036 Goyanes, A., Madla, C.M., Umerji, A., Duran Piñeiro, G., Giraldez Montero, J.M., Lamas Diaz, M.J., Gonzalez Barcia, M., Taherali, F., Sánchez Pintos, P., Couce, M.L., et al., 2019. Automated Therapy Preparation of Isoleucine Formulations Using 3D Printing for the Treatment of MSUD: First Single-Centre, Prospective, Crossover Study in Patients. Int. J. Pharm., 567, pp. 118497. Guerin, D., 2014. Louisiana Tech researchers use 3D printers to create custom medical implants. Available from: http://news.latech.edu/2014/08/20/louisiana-tech-researchers-use-3d-printers-to-create-custom-dical-implants/ [Last accessed 15 November, 2015] He, W., Huang, S., Zhou, C., Cao, L., Yao, J., Zhou, J., Wang, G., Yin, L., 2014. Bilayer matrix tablets for prolonged actions of metformin hydrochloride and repaglinide, AAPS PharmSciTech, 16, pp. 344–353. He, W., Li, Y., Zhang, R., Wu, Z., Yin, L., 2014. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: Preparation and in vitro/in vivo evaluation. Int. J. Pharm., pp. 223–231. Isreb, A., Baj, K., Wojsz, M., Isreb, M., Peak, M., Alhnan, M.A., 2019. 3D printed oral theophylline doses with innovative’ radiator-like’ design: impact of polyethylene oxide (PEO) molecular weight, Int. J. Pharm., 564, pp. 98–105. https://doi.org/10.1016/j.ijpharm.2019.04.017 Jamróz, W., Kurek, M., Łyszczarz, E., Szafraniec, J., KnapikKowalczuk, J., Syrek, K., et al. 2017. 3D printed orodispersible films with aripiprazole. Int J Pharm., 533(2), pp. 413–420. Kadry, H., Al-Hilal, T.A., Keshavarz, A., Alam, F., Xu, C., Joy, A., Ahsan, F., 2018. Multipurposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption, Int. J. Pharm., 544(1), pp. 285–296. https://doi. org/10.1016/j.ijpharm.2018.04.010 Khaled, S.A., Burley, J.C., Alexander, M.R., Roberts, C.J., 2014. Desktop 3D Printing of Controlled Release Pharmaceutical Bilayer Tablets. Int. J. Pharm., 461, pp. 105–111.